Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0. (Q36841783)
Jump to navigation
Jump to search
scientific article published on June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0. |
scientific article published on June 2007 |
Statements
Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0. (English)
Thasia Woodworth
Daniel E Furst
Rieke Alten
Clifton O Bingham
David Yocum
Victor Sloan
Wayne Tsuji
Randall Stevens
James Fries
James Witter
Kent Johnson
Marissa Lassere